Your Notifications
All done, no notifications

CAR-T Cost in Phu Quoc

Costs starts from USD30000 to USD50000
Filters

Cost of CAR-T in Major cities of Vietnam

CityMinimum Cost (USD)Minimum Cost (VND)Maximum Cost (USD)Maximum Cost (VND)
Can ThoUSD 30000778950000USD 500001298250000
Da NangUSD 30000778950000USD 500001298250000
Ha NoiUSD 30000778950000USD 500001298250000
Ho Chi MinhUSD 30000778950000USD 500001298250000
Nha TrangUSD 27000701055000USD 450001168425000
Phu QuocUSD 27000701055000USD 450001168425000

Need Help Planning Your Treatment Abroad?

Your 24/7 AI Health Assistant

CAR T-cell therapy represents a groundbreaking approach to harnessing the power of the body's immune system to combat cancer. By modifying T cells, a subset of white blood cells, in a laboratory setting, these cells are empowered to recognize and eliminate cancer cells with precision. Often categorized as a form of cell-based gene therapy, CAR T-cell therapy involves altering the genetic makeup of T cells, equipping them with the ability to target specific cancer antigens.

This innovative treatment has demonstrated remarkable efficacy, particularly in cases where conventional therapies have proven ineffective. Its ability to reprogram the immune system to target and destroy cancer cells marks a significant advancement in cancer treatment strategies.

Classification:

CAR T cell therapy is classified as follows:

  • Structure-based classification:
  • First-generation CAR T-cells: These CAR T-cells typically consist of an antigen-binding domain (single-chain variable fragment, scFv) linked to a T-cell activation domain, such as the CD3ζ chain. They lack additional co-stimulatory domains.
  • Second-generation CAR T-cells: These CAR T-cells include an additional co-stimulatory domain, such as CD28 or 4-1BB (CD137), along with the CD3ζ chain. The presence of co-stimulatory domains enhances T-cell activation and persistence.
  • Third-generation CAR T-cells: These CAR T-cells incorporate two co-stimulatory domains along with the CD3ζ chain, aiming to further enhance T-cell function and anti-tumor activity.

Antigen-based classification: It includes

  • CD19-targeted CAR T-cells: CD19 is a common target for CAR T-cell therapy and is used in the treatment of B-cell malignancies such as acute lymphoblastic leukemia (ALL) and certain types of lymphoma.
  • Other antigen-targeted CAR T-cells: CAR T-cells can be engineered to target a variety of antigens expressed on cancer cells, including but not limited to BCMA (B-cell maturation antigen), CD22, CD30, and EGFRvIII.

Would you like some help? We are available.

Get Help
Explore Hospitals ( 1 )
CAR-T in Vinmec Phu Quoc Hospital: Costs, Top Doctors, and Reviews

Phu Quoc, Vietnam

  • Joint Commission International, or JCI
  • Phu Quoc Island lacked access to modern, high-quality healthcare infrastructure suitable for both its residents and the growing number of tourists.
  • The local healthcare system faced challenges in meeting international standards for emergency, diagnostic, and speciality care.
  • There was a strong demand for a facility that could offer comprehensive and reliable medical services across a wide range of specialities.
  • Vinmec Phu Quoc General Hospital was launched in June 2015 as part of the Vinmec Healthcare System to close this healthcare gap.
  • Spanning over 10,000 square meters, the hospital comprises six stories and features nearly 150 patient beds to cater to a diverse range of medical needs.
  • Operates in line with internationally recognised standards, such as those outlined by the Joint Commission International (JCI), to ensure patient safety and service excellence.
  • Outfitted with advanced diagnostic and treatment technologies, including MRI, CT scanners, digital X-rays, and more to support high-precision care.
  • Maintains 24/7 emergency response capabilities to address critical cases at any time.
  • Engages highly qualified healthcare providers, including doctors and specialists who have trained and worked at prestigious hospitals both within Vietnam and internationally.
  • The hospital’s design emphasises eco-friendliness and natural lighting, fostering a therapeutic environment for patients.
  • To offer premium healthcare services on Phu Quoc Island, aligned with international benchmarks and suitable for both domestic and global patients.
  • To contribute to Vinmec’s vision of becoming a leader in academic medicine through research, education, and clinical excellence.
  • To ensure that every patient receives compassionate, ethical, and highly skilled care tailored to their unique health needs.
  • To position Vinmec Phu Quoc as a trusted medical destination that combines advanced technology, modern infrastructure, and exceptional patient service.

Need Some Advice From Our Experts?

Request a Call Back Now!

Our team of healthcare experts would be happy to assist you

trusted Patientstrusted Patients+99
Trusted by 50000+ Patients
Required | alphabets and spaces
Required | A valid, working email address
Required | A valid contact

Instantly Connect with our CAR-T Specialists

Doctor 1
Doctor 2
Doctor 3
Doctor 4
Doctor 5
Doctor 6
Doctor 7
Doctor 8
Our Services to Better your Experience

Opinion & Option

We submit the most accurate opinion and options from one or more countries for your review

Consult Privately

Consult with a certified specialist privately on our telemedicine platform even before you decide to travel

Logistics

We handle flights, visas, transfers, and accommodation—so you can focus on your health.

Recovery

Our In-house rehabilitation service packages to better your recovery and treatment outcome

Other Popular Countries for CAR-T

Our network connects you with the leading medical tourism destinations globally, offering a wide range of cities, top doctors, and flexible pricing options.

Thailand
Italy
United Kingdom
Singapore

Author

Dr. Vishwas Kaushik

MBBS, MD

5 Years of Experience

Dr. Vishwas Kaushik is a qualified medical professional holding an MBBS from the prestigious Belgorod State University, Russia, with a strong foundation in clinical medicine and healthcare practice. His comprehensive medical training has equipped him with a profound understanding of evidence-based clinical practices, patient-centered care, and the evolving landscape of modern medicine. With a keen interest in medical research and scientific communication, he consistently translates complex clinical concepts into clear, accurate, and accessible content for diverse audiences. His work reflects a deep commitment to advancing medical knowledge, delivering impactful healthcare insights, and bridging the gap between clinical expertise and accessible medical communication.. View More

Reviewer

Dr Prateek Varshney

Surgical Oncologist

15 Years of Experience

Dr. Prateek Varshney is a renowned Surgical Oncologist. He has experience of more than 15+ years in surgical Oncology. He is currently practicing as a consultant at Metro Mass Hospital and Cancer Institute. He was also previously associated as a consultant with Sir Ganga Ram Hospital and as a professor at Gujarat Cancer Research Institute. View More